Study of the Safety, Tolerability and Immune Response of TBE Vaccines Administered to Healthy Children

A Phase IV, Randomized, Controlled, Single-Blind, Multi-Center Study in Children to Evaluate the Safety, Tolerability and Immunogenicity of Two TBE Vaccines Administered According to Two Different Schedules.

The purpose of this study is to evaluate the safety, immunogenicity and tolerability of TBE vaccines administered to children.

Inclusion Criteria:

• Healthy male and female children, 1 to 10 years of age.

Exclusion Criteria:

• Subjects with documented evidence of TBE
• Subjects, who have been previously vaccinated against TBE